STLN

The Oncology Institute, Inc. (STLN)

Healthcare • NASDAQ$6.13-5.18%

Key Fundamentals
Symbol
STLN
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Care Facilities
Price
$6.13
Daily Change
-5.18%
Market Cap
$658.89M
Trailing P/E
N/A
Forward P/E
N/A
52W High
$7.05
52W Low
$2.32
Analyst Target
$9.00
Dividend Yield
N/A
Beta
0.42
About The Oncology Institute, Inc.

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with the

Company website

Research STLN on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Pricing · Terms · Privacy · ·

Loading...